Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia-Reference-Cited by-同舟云学术

Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia

Published:2018-11 Issue:11 Volume:44 Page:1818-1823
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Galan Alexandre,Rousset Pascal^ORCID,Mercier Frederic,Képénékian Vahan,Valette Pierre-Jean,Glehen Olivier^ORCID,Passot Guillaume

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference30 articles.

1. The etiology, clinical presentation, and management of pseudomyxoma peritonei;Moran;Surg Oncol Clin N Am,2003

2. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study;Smeenk;Eur J Surg Oncol EJSO,2008

3. Epidemiology of peritoneal mesothelioma: a review;Boffetta;Ann Oncol,2007

4. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma;Blackham;Eur J Clin Med Oncol,2012

5. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005;Moolgavkar;Cancer Causes Control,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review;European Journal of Surgical Oncology;2023-05

2. The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Current Oncology;2022-11-29

3. A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Cancers;2022-06-09

4. The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2022-06-01

5. Validation of bedside ultrasound to predict lumbar muscle area in the computed tomography in 200 non-critically ill patients: The USVALID prospective study;Clinical Nutrition;2022-04